Inventor · disambiguated record
Emma Sharp
Also filed as: SHARP EMMA · SHARP Emma Kay
19 granted patents·10 pending applications·157 citations·filing 2008–2025
94Inventor score
Files withINTERCEPT PHARMACEUTICALS INC11REYNOLDS TOBACCO CO R9RENEO PHARMACEUTICALS INC3PORTOLA PHARM INC2COLUCID PHARMACEUTICALS INC1
Top patents by PatentIndex Score
29 records- 0197US11136305B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2020·Granted Oct 5, 2021·7 cites·13 claims
- 0297US9738622B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2015·Granted Aug 22, 2017·72 cites·4 claims
- 0394US9896429B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2015·Granted Feb 20, 2018·10 cites·7 claims
- 0494US9732116B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·20 cites·10 claims
- 0593US10556880B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2017·Granted Feb 11, 2020·13 cites·14 claims
- 0693US10464917B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2018·Granted Nov 5, 2019·7 cites·6 claims
- 0791US10865192B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2019·Granted Dec 15, 2020·8 cites·19 claims
- 0890US9238673B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2013·Granted Jan 19, 2016·12 cites·23 claims
- 0988US11267795B2Crystalline PPAR-delta agonistRENEO PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·4 cites·16 claims
- 1084US2025011360A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1183US2023340010A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1281US10047117B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Aug 14, 2018·2 cites·13 claims
- 1378US12454517B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2021·Granted Oct 28, 2025·0 cites·20 claims
- 1475US2025163019A1Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2025·Application pending·0 cites
- 1574US12077518B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2020·Granted Sep 3, 2024·0 cites·27 claims
- 1674US10155787B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·1 cites·15 claims
- 1773US2021395293A1Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1871US10301287B2Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylateTOBIRA THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·1 cites·44 claims
- 1970US2024002356A1Crystalline ppar-delta agonistRENEO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2067US11713301B2Crystalline PPARδ agonistRENEO PHARMACEUTICALS INC·Filed 2022·Granted Aug 1, 2023·0 cites·19 claims
- 2166US2019153020A1Preparation and Uses of Obeticholic AcidINTERCEPT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2265US10174073B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Jan 8, 2019·0 cites·61 claims
- 2358US9982008B2Preparation and uses of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2015·Granted May 29, 2018·0 cites·14 claims
- 2458US2009156620A1[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related theretoPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 2554US11584735B2Solid forms of a plasma kallikrein inhibitor and salts thereofKALVISTA PHARMACEUTICALS LTD·Filed 2018·Granted Feb 21, 2023·0 cites·15 claims
- 2652US11053214B2Compositions and methods related to pyridinoylpiperidine 5-HT1F agonistsCOLUCID PHARMACEUTICALS INC·Filed 2017·Granted Jul 6, 2021·0 cites·7 claims
- 2751US2018305397A1Preparation and Uses of Obeticholic AcidINTERCEPT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2849US2009042916A1[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related theretoPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 2945US2012129876A1[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related theretoSHARP EMMA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emma Sharp files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →